MEDIA | Biotech Dispatch
Biotech Dispatch has shared Avecho’s announcement that it has signed an exclisive ten-year development and licensing agreement with Sandoz for the commercial rights to the Comapny’s Pase III cannabidiol capsule for insomnia in Australia.